 | Adial Pharmaceuticals, Inc | |||
| NCM : ADIL || Location: United States | ||||
$1.73+0.02 (+1.17%) |
0.14 M | 1.62 - 1.76 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 1.010 M |
| March 28, 2024 | 0.009 M |
| March 15, 2024 | 0.106 M |
| Feb. 29, 2024 | 0.028 M |
| Feb. 15, 2024 | 0.173 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.78 | -1.35 | -74.15% |
| 09/30/2023 | -1.16 | -1.18 | -1.93% |
| 06/30/2023 | -1.53 | 0.96 | 162.75% |
| 03/31/2023 | -3.57 | -2.75 | 22.97% |
| 12/31/2022 | -3.82 | -2.75 | 28.10% |
ADIL Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 4.055M | Shares Float | 3.938M |
| Short Float | 1.010M | Market Cap | 7.02M |
| Institution ownership | 6.52% | Insider ownership | 4.038% |
| Earnings Date | 05/10/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -4.91 | Forward EPS | -1.59 |